ABVC BioPharma, Inc. reported that from April 30 to May 9, 2025, it sold 1,030,413 shares of common stock to 22 non-U.S. investors, raising approximately $619,625, and accepted additional subscriptions of $670,000 on May 27, 2025, for an additional 957,144 shares.